Replies to post #525999 on NorthWest Biotherapeutics Inc (NWBO)

[pgsd]

"In that NWBO owns FlaskWorks they'll be partnering or acquiring far more than a couple vaccines from NWBO. The FlaskWorks patents may well become the basis for many personal products, each may be somewhat different from others, but they'll all utilize FlaskWorks patents and NWBO or whoever purchases it will earn money from what's utilizing it whether it's a product that's owned by the BP, or by a competitor"

Totally agree with your points on Flaskworks, having this technology is one of the reasons why I much prefer a partnership(s) to a buyout :-)

[jimmy667]

Gary, I agree NWBO might have a widely applicable platform technology in the personalized biologic manufacturing space analogous to Illumina in the genome sequencing space. That is the say virtually occupying 90% of the market.